4/A: Sight Sciences CTO Amends Ownership Report
Insider Ownership Amendment
Sight Sciences' Chief Technology Officer, David Badawi, filed an amended Form 4 to correct previously reported beneficial ownership of common stock and derivative securities.
Summary
- An amendment to a Form 4 filing was submitted by David Badawi, Chief Technology Officer and Director of Sight Sciences, Inc.
- The amendment corrects previously reported beneficial ownership of common stock and stock options.
- Specifically, 7,460 shares acquired from option exercise prior to the July 2021 Initial Public Offering were inadvertently included as underlying options in Table II of a previous Form 3.
- These 7,460 shares are now correctly reported as direct beneficial ownership of common stock in Table I, bringing the total direct beneficial ownership of common stock to 1,448,656 shares.
- The expiration date for certain stock options was corrected from January 8, 2027, to February 28, 2026.
- Following the reported transaction (exercise of 40,000 options), 42,540 derivative securities (stock options) are beneficially owned.
Sentiment
Score: 5
Explanation: Neutral. The filing is a clerical correction of previously reported insider ownership data, neither positive nor negative for the company's operational or financial performance.
Positives
- Accuracy of beneficial ownership reporting for the Chief Technology Officer has been improved.
- Compliance with SEC reporting requirements is maintained through the correction.
Negatives
- An initial misclassification of 7,460 shares and an incorrect option expiration date necessitated an amendment.
Risks
- Inaccurate or delayed insider transaction reporting can lead to misinterpretation of executive holdings by investors.
Future Outlook
No forward-looking statements or guidance regarding the company's operational or financial performance are provided.
Industry Context
This amendment is a routine compliance update for insider ownership and does not reflect broader industry trends or competitive dynamics.
Stakeholder Impact
- Shareholders receive more precise and accurate information regarding a key executive's equity holdings, enhancing transparency.
- Regulatory bodies are provided with corrected data, ensuring adherence to disclosure standards.
Key Dates
| Date | Description |
|---|---|
| 2017-01-01 | 25% of stock options granted to David Badawi vested. |
| 2020-01-01 | All stock options granted to David Badawi fully vested and exercisable. |
| 2021-07 | Issuer's Initial Public Offering (IPO) completed. |
| 2021-07-14 | Original Form 3 filed by David Badawi, which contained initial reporting errors. |
| 2022-09-21 | Date of original Form 4 filing being amended, and date of earliest transaction reported. |
| 2025-12-30 | Date the amended Form 4/A was signed by attorney-in-fact for David Badawi. |
| 2026-02-28 | Corrected expiration date for certain stock options. |
Keywords
Sight Sciences, SGHT, Form 4/A, Beneficial Ownership, Insider Trading, Stock Options, CTO, David Badawi, SEC Filing, Amendment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.